Deals channel feed

Ei­sai, BioArc­tic to de­vel­op new drug for Alzheimer’s that can cross blood-brain bar­ri­er

Last year
R&D

Boehringer In­gel­heim inks chron­ic liv­er dis­ease re­search pact with Ochre Bio

Last year
R&D

Bruk­er to ac­quire trou­bled spa­tial bi­ol­o­gy com­pa­ny NanoS­tring for $392M

Last year

Sanofi's trimmed on­col­o­gy plans lead to $3B biobucks dent for IGM

Last year
R&D

Ab­b­Vie inks deal for Med­in­cell's long-act­ing in­jectable plat­form worth up to $1.9B

Last year
Pharma

ADC deal­mak­ing is red hot. Is it sus­tain­able?

Last year
Pharma

Il­lu­mi­na re­ceives EU clear­ance for planned Grail di­vest­ment

Last year
Diagnostics

Adap­ti­m­mune los­es $3B biobucks pact with Genen­tech

Last year
R&D

I-Mab CEO de­tails con­sid­er­a­tions be­hind Chi­na split, hints at po­ten­tial in-li­cens­ing

Last year
China

No­var­tis want­ed just one drug from Mor­phoSys be­fore up­ping bid for whole com­pa­ny, doc­u­ment re­veals

Last year
Pharma

No­var­tis lines up pro­tein de­grad­er deal with Pfiz­er-al­lied Arv­inas

Last year

Ver­tex strikes $4.9B deal for Alpine, ex­pand­ing work in kid­ney and au­toim­mune dis­ease

Last year

Alpine Im­mune Sci­ences, Janux said to be look­ing at pos­si­ble sales — re­ports

Last year
Pharma

Sanofi to di­vest can­cer biotech it bought for $1B, axe 100 staffers in Cal­i­for­nia

Last year
People

Gink­go, No­vo Nordisk forge ‘flex­i­ble’ re­search pact, from dis­cov­ery to man­u­fac­tur­ing

Last year
Manufacturing

Big come­back? The Q1 re­port on biotech is in, and there’s been some sput­ter­ing

Last year
Financing
Bioregnum

Boehringer In­gel­heim taps Sino Bio­pharm as Chi­nese part­ner for its emerg­ing can­cer pipeline

Last year
China

Mer­ck signs small ac­qui­si­tion to make AD­Cs safer

Last year
Startups

Catal­ent had sev­er­al suit­ors, in­clud­ing an­oth­er of its busi­ness part­ners, be­fore No­vo won out

Last year
Manufacturing

Ic­ahn gives up seat on Il­lu­mi­na board, back­ing away from chal­lenge to di­ag­nos­tics com­pa­ny

Last year
Diagnostics

J&J buys an­oth­er medtech com­pa­ny in $13.1B Shock­wave deal

Last year
Pharma

Clock for FTC’s re­view of No­vo Hold­ings' $16.5B Catal­ent buy restarts af­ter re­fil­ing

Last year
Manufacturing

Mer­ck KGaA inks ADC dis­cov­ery deal with AI tech­bio worth up to $1.4B in mile­stones

Last year
R&D

Q&A: Gen­mab CEO on ink­ing the first ac­qui­si­tion in the com­pa­ny's 25-year his­to­ry

Last year
Pharma
First page Previous page 16171819202122 Next page Last page
A service from the Financial Times